Author:
Chatzivasileiou Souzana,Emmanouil-Kalos Alkinoos,Efthymiou Iris Panagiota,Batakis Dimitris,Vozikis Athanassios
Abstract
Pharmaceutical companies are major donors to medical-related civil society organizations worldwide, which has raised concerns about their influence on public health policy. The support provided includes financial donations, in-kind contributions and collaborations in research and awareness initiatives. However, there is a lack of transparency when it comes to these donations. While they contribute to the ability of recipient organizations to meet their operational needs and to conduct research, they also raise questions about the role of pharmaceutical companies in the formulation of public health policies. This paper aims to map the donations made by pharmaceutical companies to scientific societies in Greece, examining the nature and extent of the support provided, as well as examining the impact of these donations on the scientific community. Finally, recommendations are provided on how transparency and accountability can be strengthened. Further research is needed to understand the full extent of these donations and their impact on public health governance in Greece.
Publisher
National Documentation Centre (EKT)
Reference36 articles.
1. Association of the British Pharmaceutical Industry. (2021). Code of Practice for the Pharmaceutical Industry 2021. Available at: https://www.abpi.org.uk/publications/code-of-practice-for-the-pharmaceutical-industry-2021/
2. Bagire, V., Aosa, E. & Awino, Z. B. (2014). A Synthesis of the Strategic Orientations and NGO Legitimacy in the African Economic Setting. Journal of Business and Economics, 5(8), 1358-1373.
3. Ball, D. E., Tisocki, K., & Herxheimer, A. (2006). Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey. BMC Public Health, 6(1), 1-12.
4. EFPIA (2017). Working together with patient groups. European Federation of Pharmaceutical Industry Asociations.
5. Fabbri, A., Swandari, S., Lau, E., Vitry, A., & Mintzes, B. (2019). Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis. International Journal of Health Services, 49(2), 273–293. https://doi.org/10.1177/0020731418823376